Sentien Biotechnologies, Inc. — Form D
Sentien Biotechnologies, Inc. of MEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-12. The offering totals $1.2M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-08-12
- Form: D
- Accession: 0001650699-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $1.0M
- Remaining: $150K
- Investors: 1
- Date of first sale: 2015-08-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245621
Issuer
- Name: Sentien Biotechnologies, Inc.
- CIK: 0001650699
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 196 BOSTON AVENUE, MEDFORD, MA, 02155
- Phone: 617-674-5100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Greg Bailey | Director | Gainesville, FL |
| Rich Ganz | Director | San Francisco, CA |
| Martin Heidecker | Director | Cambridge, MA |
| Brian Miller | Director | Vancouver, A1 |
| Biju Parekkadan | Director | Medford, MA |
| Brian Miller | Executive Officer | Vancouver, A1 |
More